NPY Antibody

1. Neuropeptide Y (NPY) is a pleiotropic gene implicated in stress resilience and is associated with higher levels of conscientiousness. Along with environmental factors such as stressful life events, this gene may be a factor in the neurobiology of human personality. PMID: 29494882
2. We found the suicide-associated gene coexpression network. The reconstructed network consisted of 104 genes. Topological analysis showed that in total, CCK, INPP1, DDC, and NPY genes are the most fundamental hubs in the network. PMID: 29381655
3. Data indicated that NPY plays a protective role in ER stress-induced neuronal cell death through activation of the PI3K-XBP1 pathway. PMID: 29650257
4. This study provided proof that SNPs within NPY is significantly associated with the susceptibility to and the prognosis of cervical vertigo. PMID: 29197114
5. Data suggest that up-regulation of NPY inhibits proliferation of adipose-derived stem cells while promoting adipogenesis and up-regulating expression of white adipocyte biomarkers PPARG, CEBPA, CIDEC, and RIP140. (PPARG = peroxisome proliferator activated receptor gamma; CEBPA = CCAAT/enhancer-binding protein alpha; CIDEC = cell death-inducing DFFA-like effector C; RIP140 = nuclear receptor interacting protein 1) PMID: 28954935
6. results are the first to demonstrate that functional NPY variation alters chronic stress-related vagal control, suggesting a potential parasympathetic role for NPY gene in stress regulation PMID: 27527739
7. Medium chain triglyceride nutritional supplementation increased the amount of activated ghrelin and NPY in anorexia nervosa patients. PMID: 28361739
8. Analysis indicates that low levels of NPY in psychogenic non-epileptic seizure patients may confer greater vulnerability to exhibit seizure-like symptoms and lower quality of life. PMID: 28927333
9. The rs16147 genotype affected the reduction in insulin resistance and insulin levels in response to two different hypocaloric diets in obese subjects, with a lack of response in subjects with the major allele. PMID: 28787737
10. We found that the NPY gene rs16147 SNP was related to the change in insulin levels, homeostasis model assessment-insulin resistance, CRP, IL-6 and waist circumference at 3 months after a hypocaloric low-fat diet. PMID: 27599771
11. genetic variation in NPY and NPY2R is at low frequency and thus does not make a major contribution to the obese phenotype in the general population PMID: 28857123
12. Genetic risk score (GRSNPY) analysis found twelve significant (P<0.05) serum NPY concentration related SNPs among alpha7 nicotinic acetylcholine receptor gene CHRNA7, insulin receptor gene INSR, leptin receptor gene LEPR, glucocorticoid receptor (GR) gene NR3C1, and NPY gene. However, after permutation test of gene score the predictive value of GRSNPY remained non-significant (P=0.078). CONCLUSIONS: Serum NPY level ... PMID: 27837667
13. In obese males, the rs164147 polymorphism of the NPY gene is associated with leptin, insulin level, HOMA-IR, and an increased risk of MetS and its related phenotypes, such as central obesity and hyperglycemia. PMID: 27788523
14. Both structural (+1128T/C) and promoter polymorphisms (-399 T/C) of Neuropeptide Y are strongly associated with type-II diabetes susceptibility in Gujarat population which at least in part, may result in higher levels of Neuropeptide Y thereby suggesting its crucial role in type-II diabetes susceptibility. PMID: 27749914
15. Hypermethylation of WIF1 (WNT inhibitory factor 1) and NPY (neuropeptide Y) genes was significantly higher in tumor tissue compared to normal tissue, independently of tumor stage. PMID: 27251038
16. Our results provided clinical evidences for NPY participating in the bone healing process in a nonhypothalamic manner, most probably by directly promoting osteogenesis of mesenchymal stem cells. PMID: 27720230
17. In conclusion, the obtained results demonstrate the probable role of NPY SNPs in susceptibility to multiple sclerosis within the Iranian population. PMID: 27559040
18. Neuropeptide Y is the best dipeptidyl peptidase 4 (DPP4)-substrate in blood, being truncated by soluble and membrane DPP4, respectively. The decline of soluble DPP4 in acute depression could be reversed upon anti-depressive treatment. PMID: 26988064
19. The CT genotype of rs5574 and the GT genotype of rs17149106 are significantly associated with prevalent asthma. PMID: 27469060
20. study implicates NPY as a potential target in antihypertensive therapies for preeclampsia patients PMID: 26431933
21. NPY is efficiently cleaved by FAP indicating a potential function for FAP in neuropeptide regulation within liver and cancer biology. PMID: 26621486
22. NPY plays important roles in the pathogenesis and pathophysiology of pituitary adenomas, as shown in this clinical study. PMID: 26683132
23. NPY levels were higher in both obese and non-obese PCOS patients compared to healthy controls. PMID: 26291814
24. minor autoantigen in children with newly diagnosed type 1 diabetes PMID: 25258030
25. s observed that NPY levels were decreased in two Machado-Joseph disease patients' cerebella. PMID: 26220979
26. Suggest IL-4 as marker of allergic airway inflammation in asthma, and roles for adiponectin and neuropeptide Y in neurohormonal signaling. PMID: 26111352
27. This study suggests that NPY rs16147 T and rs16139 C minor alleles are associated with increased risk, whereas the minor allele T of the rs5574 is associated with a reduced risk of obesity. PMID: 26240981
28. NPY expression is increased during atherogenesis and in particular in unstable plaques PMID: 24858338
29. Immunohistochemical distribution of this peptide in the epidermal skin (from abdomen, breast and face) of healthy women was analysed. PMID: 26002416
30. The C-terminal alpha-helix of Neuropeptide Y, which is formed in a membrane environment in the absence of the receptor, is unwound starting at T(32) to provide optimal contacts in a binding pocket within the transmembrane bundle of the NPY-Y2 receptor. PMID: 25924821
31. Data suggest that nutritional status and up-regulation of NPY in cerebrospinal fluid are related to disease progression in adults with chronic kidney disease (CKD); up-regulation of serum NPY levels may predict risk of cardiovascular events in CKD. PMID: 25920420
32. in AN patients, the NPY system is not up-regulated by chronic undernutrition suggesting that this may play a role in the inability of anorectic women to adapt food intake to their energy demand. PMID: 25798605
33. The mean neuropeptide-Y level was 62.29 +/- 13.89 pg/mL in the breath-holding spells group and 58.24 +/- 12.30 pg/mL in the control group. PMID: 26021463
34. neuropeptide Y has a role in Ewing sarcoma bone invasion PMID: 25714031
35. study is the first to observe a sexually dimorphic role of alleles at NPY in humans and support previous genome-wide findings of a role of NPY in severe PD. PMID: 25256105
36. Data suggest that an SNP in NPY (rs16147) is associated with change in abdominal adiposity in subjects with central obesity in response to dietary interventions (low/high fat); T allele carriers on high-fat diet regained abdominal fat. PMID: 26156739
37. The data are in line with the hypothesis that NPY signaling is altered in affective disorders and states of emotional dysregulation. PMID: 25453484
38. The rs16147 polymorphism may be associated with presence of metabolic syndrome (MetS) among subjects with documented coronary artery disease (CAD). Carriage of NPY A allele in patients with CAD is associated with a higher prevalence of MetS. PMID: 24897239
39. This study suggests that the rs16147 polymorphism in the NPY gene may not be a potential contributor to the risk of CAD in an Iranian population. PMID: 25427865
40. relationship existed between serum NPY and depressive disorders, posttraumatic stress disorder, and resilience. PMID: 24709369
41. NPY may be a possible contributor to metabolic syndrome and associated cancer for the Han ethnic group. PMID: 25081719
42. Distribution of peptidergic populations in the human dentate gyrus (somatostatin [SOM-28, SOM-12] and neuropeptide Y [NPY]) during postnatal development. PMID: 24965867
43. Polymorphisms within NPY are associated with vitiligo susceptibility. PMID: 25221996
44. A putative mechanism based on NPY-induced inhibition of voltage-dependent Ca(2+) influx in pre- and post-synaptic neurons is proposed. PMID: 25026432
45. Systemic NPY levels are elevated in patients with Ewing sarcoma, and these high levels are associated with unfavorable disease features. PMID: 25387699
46. NPY and its Y receptor are possible mediators of both vasoconstriction and pulmonary vascular remodelling in pulmonary hypertension PMID: 24779394
47. Study demonstrated an interaction of NPY genotype and childhood emotional maltreatment on amygdala and posterior cingulate cortex activation during processing of emotional faces, in addition to a faster behavioral response PMID: 23482625
48. In a series of human fetuses, neuropeptide Y-containing nerve fibers was present and could be detected as early as in the pineal of four- to five-month-old fetuses. PMID: 24757681
49. BIBP-3226 was used to antagonize Y(1)-receptors, NPY to test the efficacy of the antagonism. PMID: 24213859
50. Neuropeptide Y has fungicidal, antimicrobial activity against Candida albicans. PMID: 9756788

显示更多

收起更多

HGNC: 7955

OMIM: 162640

KEGG: hsa:4852

STRING: 9606.ENSP00000242152

UniGene: Hs.1832